BRANFORD, Conn. - Azitra, Inc. (NYSE American:AZTR), a clinical-stage biotech company currently trading near its 52-week low of $0.68, announced positive preclinical results for its ATR-01 program ...

Investing.com -- Azitra Inc (NYSE:AZTR) stock surged 42.3% in premarket trading Monday following the announcement of positive preclinical data for its ATR-01 program targeting ichthyosis vulgaris, a ...

Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...

ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgaris Preclinical data show production of active, functional filaggrin delivered ...

Recruitment of Three Additional Pediatric Patients in Austria and Ireland Achieves Investigator Study TargetCurrent Pediatric Patient in Ongoing ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Reggae artist Jah Cure faces the possibility of a longer prison sentence, as Dutch prosecutors have signalled their intention to pursue a prison sentence of 9.5 years on the charge of attempted murder ...

Amanah’s arts, culture, and sports bureau chairperson Wan Anwar Wan Ibrahim has urged the government, as the owner of Petronas, to take internal action against the company’s president and group chief ...

Sam Altman is free to pursue his goal of using artificial intelligence to cure cancer after signing off on another apparent priority: allowing OpenAI to create pornography. On Tuesday afternoon, ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Sources familiar with the situation tell PEOPLE the former president is doing well and responding to treatment Nicholas Rice is a Senior Editor for PEOPLE Magazine. He began working with the brand as ...